| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0152 | 14,15-eeze | Antagonist of EpETrE-induced relaxation of vascular smooth muscle |
|
| DCC0153 | 14-3-3 Dimer Ligand | The First Ligand Targeting the Dimerization Interface of the 14-3-3ζ Adapter Protein |
|
| DCC0154 | 15-epi-lipoxin A4 | Natural inhibitor of TNF-α-induced tissue factor (TF) expression via the PI3K/AKT/ NF-κB axis in human umbilical vein endothelial cells |
|
| DCC0155 | 15-hete | Inhibitor of monocyte/macrophage infiltration and the expressions of intercellular adhesion molecules under hypoxia |
|
| DCC0156 | 163-bp3 | Potent clickable photoaffinity probe, targeting gamma-secretase |
|
| DCC0157 | 163-bpyne | Notch-sparing |
|
| DCC0158 | 17,18-dihete | Major metabolite of eicosapentaenoic acid (EPA) |
|
| DCC0159 | 17beta-hsd12 Activator A1 | Novel potent 17β-HSD12 activator |
|
| DCC0160 | 17-dmag | Potent HSP90 inhibitor |
|
| DCC0161 | 17-hydroxycativic Acid | Acetylcholinesterase (AChE) inhibitor |
|
| DCC0162 | 17-hydroxywortmannin | Irreversible inhibitor of PI3K and mTOR |
|
| DCC0163 | 17ß-hsd2-in-24 | Novel potent inhibitor of 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) |
|
| DCC0164 | 17β-hsd1 Inhibitor 1 | Novel inhibitor of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), being highly selective over 17β-HSD2 |
|
| DCC0165 | 18bioder | Novel Neuroprotective GSK-3β Inhibitor, highly selectively inhibiting HIV-1; The second generation derivative of 6BIO |
|
| DCC0166 | 1-benzyl-i3c | Highly potent inhibitor of Wnt/βcatenin signaling in melanoma cells, coordinately inhibiting cell proliferation and disrupts expression of Microphthalmia Associated Transcription Factor isoform M, also inhibiting NEDD4-1 |
|
| DCC0167 | 1-deoxy-d-allulose | Strong growth inhibitor as an antimetabolite |
|
| DCC0168 | 1-hex-6azglcnac | Reporter molecule functionalized at the anomeric position, exhibiting robust labeling over background with negligible amounts of nonspecific chemical labeling in cell lysates |
|
| DCC0169 | 1-hex-glcnalk | Reporter molecule functionalized at the anomeric position, exhibiting robust labeling over background with negligible amounts of nonspecific chemical labeling in cell lysates |
|
| DCC0170 | 1h-thieno[2,3-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0171 | 1h-thieno[3,2-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0172 | 1h-thieno[3,4-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0173 | 1-nitro-2-phenylethane | The first organic NO2-containing molecule isolated from plants, stimulating the soluble guanylate cyclase-cGMP pathway |
|
| DCC0174 | 1ß-hydroxy Vitamin D3 | inactive isomeric impurity of Alphacalcidol |
|
| DCC0175 | 2,2'-dioh-5,5'-dif-dppen | Novel inhibitor of thioredoxin reductase (TrxR) |
|
| DCC0176 | 2,3-acbt 1p | Novel potent antiangiogenic agent, binding to VEGFR2, significantly reducing neovascularization in both ex vivo and in vivo angiogenic assays without affecting the proliferation of endothelial cells |
|
| DCC0177 | 2',3'-dihydroxypuberulin | Natural Inhibitor for FcεRI expression on mast cell from Verbasucum thapsus L |
|
| DCC0178 | 2,3-dmb-pp1 | Inhibitor of SykM442A S505A ASKA- (analog-sensitive kinase alleles) mediated cellular calcium flux |
|
| DCC0179 | 2,4-bis(p-hydroxyphenyl)-2-butenal | Concentration- and time-dependent inhibitor of the growth of NSCLC cells inducing apoptosis |
|
| DCC0180 | 2,4-dichloroamphetamine Hcl | Stimulator of the central nervous system, decreasing the 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels in brain |
|
| DCC0181 | 2,5-2f-kbz | Novel Versatile Probe for Interrogating Histone Benzoylation and Interactions in Living Cells |
|
